Secukinumab for Acrodermatitis Continua of Hallopeau.
Muggli, David
Secukinumab for Acrodermatitis Continua of Hallopeau. [electronic resource] - JAMA dermatology 04 2017 - 336-337 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
2168-6084
10.1001/jamadermatol.2016.5059 doi
Acrodermatitis--diagnosis
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Biopsy
Foot Dermatoses--diagnosis
Humans
Male
Skin--pathology
Secukinumab for Acrodermatitis Continua of Hallopeau. [electronic resource] - JAMA dermatology 04 2017 - 336-337 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
2168-6084
10.1001/jamadermatol.2016.5059 doi
Acrodermatitis--diagnosis
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Biopsy
Foot Dermatoses--diagnosis
Humans
Male
Skin--pathology